KLOW
Summary
The KLOW blend is investigated for its role in tissue repair, inflammation, and cell vitality. It brings together four of the most studied regenerative peptides in a single vial—BPC-157, GHK-Cu, TB-500 (Tβ4), and KPV—designed for combined research into cytoprotection, extracellular matrix remodeling, and inflammation modulation.
What is it investigated for?
- • Comprehensive tissue repair
- • Inflammation modulation
- • Extracellular matrix and collagen remodeling
- • Cytoprotection and cell vitality
Cycle and rest
Mechanism of action
BPC-157 — Cytoprotective signaling
Pentadecapeptide derived from a gastric protein, studied for its potent cytoprotective and angiogenic activity through the VEGFR2, PI3K-Akt-eNOS, and ERK1/2 pathways.
GHK-Cu and TB-500 — Matrix and cytoskeleton
GHK-Cu upregulates extracellular matrix (collagen, elastin) and antioxidant defense genes; TB-500 reorganizes actin and directs cell migration. Together, they cover two pillars of tissue repair.
KPV — Inflammation brake
Tripeptide derived from α-MSH that modulates NF-κB and MAPK pathways, with a marked anti-inflammatory effect at mucosal and systemic levels.
Scientific evidence
BPC-157: numerous animal models describe accelerated healing of tendons, muscles, bones, and intestines.
GHK-Cu and TB-500: GHK-Cu increases collagen synthesis by 70-230% in wound models; Tβ4 has reached clinical trials for wound healing.
KPV: preclinical studies in colitis models show reduced inflammation. Honest note: human data for each component is limited, and there are no controlled studies of the combined formulation.
Product use
The KLOW blend concentrates four complementary repair mechanisms into a single reference material for in vitro and laboratory research. At Peptido BioGenetic, we offer it with high-purity components and a Certificate of Analysis (COA) available upon request.
Administration
A single application, no multiple injections. Designed for easy administration.
⚠️ Product exclusively for research and laboratory use. Not suitable for human or veterinary consumption.
Garantía de Pureza >98.5% Analizado independientemente por espectroscopia y pruebas HPLC. Empaque térmico priority incluido en el envío.
Información Clínica
Especificaciones Técnicas
- Compuesto Mezcla KLOW: BPC-157, GHK-Cu, TB-500 (Tβ4) y KPV
- Contenido 80 mg totales por vial
- Presentación Polvo liofilizado (vial)
- Pureza Verificada según estándares de laboratorio europeos · COA disponible bajo solicitud


